Research Digest

Lab notes: A compound in turmeric could make cancer cells more sensitive to radiation

Indian scientists are testing curcumin for its possible role in radiation therapy.

A major concern in cancer treatment is the tendency of some cancer cells becoming resistant to radiation therapy. Indian scientists have now deciphered how such resistance develops in cervical cancer cells, and claim that these cells can be made sensitive to radiation if treated with curcumin – a compound found in turmeric.

Cancer cells as well as tumors harbour a small population of stem cells which become resistant to drugs and radiation treatment. That is why, even after most cancer cells get killed with treatment, these cells continue to grow and cause lesions which could make cancer reappear over time.

Earlier research had suggested pivotal role of a human protein, AP-1, in development of resistance to radiation in various cancers, but how it happens was not known. The new study delineates the exact mechanism of resistance in cells from cervical cancer caused by Human Papilloma Virus. Researchers feel the mechanism could be similar in other cancers as well.

“We have identified a target for effective cancer therapy and it could allow recurrence-free survival of cancer patients in future,” said Professor Bhudev C Das, one of the lead researchers of the study published in journal Scientific Reports.

The study builds upon earlier findings that pre-treatment with curcumin – a safe herbal compound derived from turmeric – makes cancer stem cells sensitive to radiation therapy. It has found that combined effect of curcumin and exposure to radiation was markedly more effective in lowering AP-1 levels thereby rendering cells unviable for growth and replication. When treated with radiation alone, there was delayed but increased rate of proliferation and tumor formation.

The mechanism of curcumin-induced inhibition lends credibility to AP-1 as a drug target and therapeutic utility of curcumin for radio-sensitisation of cervical cancer stem cells for better treatment outcomes.

The study was undertaken jointly by scientists from the Ambedkar Centre for Biomedical Research, National Institute of Cancer Prevention and Research in Noida, Amity Institute of Molecular Medicine and Stem Cell Research, Defence Research Development Organization and Department of Zoology at the University of Delhi. The research group was led by Professor Das and Dr Alok C Bharti, and it included Abhishek Tyagi, Kanchan Vishnoi, Harsimrut Kaur, Yogesh Srivastava and Bal Gangadhar Roy.

The research was funded by Department of Science and Technology, Department of Biotechnology and Indian Council of Medical Research, among others.

This article was first published on India Science Wire.

Support our journalism by subscribing to Scroll+ here. We welcome your comments at
Sponsored Content BY 

Snippets of wisdom on the health care industry by Dr. Kevin Lofton

His sessions stressed on the importance of patient centric healthcare.

At the Hospital Leadership Summit 2017, Dr Kevin Lofton, CEO Catholic Health Initiatives, spoke on the need to focus on patient experience, the role of the leader and shared some ideas from the practices of his own hospital chain. Here are some snippets from Dr Lofton’s presentation that will provide some food for thought. The Bringing Health to Life content hub contains his and many other insights and best practices for healthcare delivery.

The two kinds of willing patients

During the summit, a consensus emerged that the health care industry needs to learn customer centricity from other industries. However, the health care industry is unique in several ways and one of the fundamental differences is the nature of its customer. Dr Lofton spoke about how the customer i.e. the patient in the health care industry is different by way of motivation. He reminded the gathering that nobody willingly seeks out a doctor.


The paradigm shift needed in health care

Dr Lofton emphasised that patient centricity needs to become a part of the very philosophy of a health care facility, a philosophy that drives every action and motivates every employee in the organisation. He described this revaluation of purpose as a paradigm shift. Dr Lofton spoke about how patient centricity starts much before the patient walks into the hospital, that the patient’s tryst with the health care system starts before a visit to the doctor is warranted. In this clip, Dr Lofton provides an example of one such paradigm shift for health care providers.


At the 2017 Hospital Leadership Summit, Dr Lofton shared several such insights from his experience in the US health care system. He emphasised especially on the need of empathy alongside clinical skill among health care providers.

For more insights and best practices for healthcare delivery, visit Abbott’s Bringing Health to Life portal.

This article was produced on behalf of Abbott by the marketing team and not by the editorial staff.